Show results for
Refine by
Clinical Development Suppliers & Manufacturers
3 companies found
based inMilan, ITALY
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,587 employees and annual total consolidated revenues of around 1,4 billion euros, 89% of which from international sales. In the ...
Pharmacovigilance is a system concerned with identifying, assessing, understanding and preventing adverse reactions as well as any other problems associated with taking medicines, with the aim to improve the treatment and safety of patients and ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
The SIK program is a strategic effort to develop assets inhibiting salt-inducible kinases (SIK) as a novel target class in inflammation which we discovered with our proprietary target discovery platform. These molecules inhibit the different members ...
based inDreieich, GERMANY
Biotest - innovation in haematology, clinical immunology and intensive care medicine. Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and ...
Trimodulin is an innovative polyvalent antibody composition, purified from human plasma. In comparison to standard IgG preparations (IVIG), trimodulin contains relevant amounts of IgM and IgA in addition to ...